Evidence map›Paper›PMID 33985607›Full record

ArticleEpidemiology and infection2021

Epidemiological assessment of 5598 brucellosis inpatients in Spain (1997-2015).

Beatriz Rodríguez-Alonso, Hugo Almeida, Montserrat Alonso-Sardón, Virginia Velasco-Tirado, Ángela Romero-Alegria, Javier Pardo-Lledias, Amparo López-Bernus, José Luis Pérez Arellano, Moncef Belhassen-García

Open access · goldAbstract read
In one paragraph

Article in Epidemiology and infection, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Predicting the Spatial-Temporal Distribution of Human Brucellosis in Europe Based on Convolutional Long Short-Term Memory Network.The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Beatriz Rodríguez-AlonsoServicio de Medicina Interna, Complejo Asistencial Universitario de Salamanca (CAUSA), Centro de Investigación de Enfermedades Tropicales de la Universidad de Salamanca (CIETUS), Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, España.
Hugo AlmeidaMedicina Interna, Unidade Local de Saude de Guarda, Guarda, Portugal.
Montserrat Alonso-SardónArea of Preventive Medicine and Public Health, Instituto de investigación biomédica de Salamanca (IBSAL), CIETUS, University of Salamanca, Salamanca, Spain.
Virginia Velasco-TiradoServicio de Dermatología, CAUSA, CIETUS, IBSAL, Salamanca, España.
Ángela Romero-AlegriaServicio de Medicina Interna, CAUSA, IBSAL, CIETUS, Salamanca, Spain.
Javier Pardo-LlediasServicio de Medicina Interna, Hospital Marques de Valdecilla, CIETUS, Avenida Valdecilla S/N, Santander, Spain.
Amparo López-BernusServicio de Medicina Interna, Infectious Diseases Section, CAUSA, IBSAL, CIETUS, University of Salamanca, Salamanca, Spain.
José Luis Pérez ArellanoInfectious Diseases and Tropical Medicine Unit, Complejo Hospitalario Universitario Insular-Materno Infantil de Gran Canaria, Las Palmas de Gran Canaria, Spain.
Moncef Belhassen-GarcíaServicio de Medicina Interna. Unidad de Enfermedades Infecciosas, CAUSA, IBSAL, CIETUS, Universidad de Salamanca, Salamanca.ORCID 0000-0002-2230-1256
Universidad de Salamanca · ESInstituto de Investigación Biomédica de Salamanca · ESHospital Universitario Insular de Gran Canaria · ESInstituto Politécnico da Guarda · PTMarqués de Valdecilla University Hospital · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Brucellosis remains one of the main zoonoses worldwide. Epidemiological data on human brucellosis in Spain are scarce. The objective of this study was to assess the epidemiological characteristics of inpatient brucellosis in Spain between 1997 and 2015. A retrospective longitudinal descriptive study was performed. Data were requested from the Health Information Institute of the Ministry of Health and Equality, which provided us with the Minimum Basic Data Set of patients admitted to the National Health System. We also obtained data published in the System of Obligatory Notifiable Diseases. A total of 5598 cases were registered. The period incidence rate was 0.67 (95% CI 0.65-0.68) cases per 100 000 person-years. We observed a progressive decrease in the number of cases and annual incidence rates. A total of 3187 cases (56.9%) came from urban areas. The group most at risk comprised men around the fifth decade of life. The average (±s.d.) hospital stay was 12.6 days (±13.1). The overall lethality rate of the cohort was 1.5%. The number of inpatients diagnosed with brucellosis decreased exponentially. The group of patients with the highest risk of brucellosis in our study was males under 45 years of age and of urban origin. The lethality rate has reduced to minimum values. It is probable that hospital discharge records could be a good database for the epidemiological analysis of the hospital management of brucellosis and offer a better information collection system than the notifiable diseases system (EDO in Spanish).

Indexed as

AdolescentAdultAgedBrucellaBrucellosisDatabases, FactualFemaleHospitalizationHumansIncidenceInpatientsLongitudinal StudiesMaleMiddle AgedRetrospective StudiesRisk FactorsBrucella sppbrucellosisepidemiologyfever of intermediate durationmalt feverMediterranean feverSpain

Identifiers

PMID33985607
PMCPMC8251665
OpenAlexW3159994647

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.